Protease-Activated Receptors: Contribution to Physiology and Disease

Physiological Reviews

Volumn 84, Issue 2, 2004, Pages 579-621

  Ossovskaya, Valeria S ^a   Bunnett, Nigel W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; LIGAND; PROTEINASE ACTIVATED RECEPTOR; SERINE PROTEINASE;

AGONIST; AMINO TERMINAL SEQUENCE; BACTERIUM; CELL PROTECTION; CELL SURFACE; CELL SURVIVAL; CIRCULATION; DESENSITIZATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; EPITHELIUM CELL; FUNGUS; HUMAN; INFLAMMATION; LIGAND BINDING; LYSOSOME; MAST CELL; NERVE CELL; NEUTROPHIL; NONHUMAN; PAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TISSUE INJURY; TISSUE REPAIR;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; INFLAMMATION; NEOPLASMS; RECEPTORS, PROTEINASE-ACTIVATED; SIGNAL TRANSDUCTION;

EID: 1642279517     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.00028.2003     Document Type: Review

References (319)

1. Abraham LA, Chinni C, Jenkins AL, Lourbakos A, Ally N, Pike RN, and Mackie EJ. Expression of protease-activated receptor-2 by osteoblasts. Bone 26: 7-14, 2000.
2. Akers IA, Parsons M, Hill MR, Hollenberg MD, Sanjar S, Laurent GJ, and McAnulty RJ. Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2. Am J Physiol Lung Cell Mol Physiol 278: L193-L201, 2000.
3. Al-Ani B, Saifeddine M, and Hollenberg MD. Detection of functional receptors for the proteinase-activated-receptor-2-activating polypeptide, SLIGRL-NH2, in rat vascular and gastric smooth muscle. Can J Phys Pharmacol 73: 1203-1207, 1995.
4. Al-Ani B, Saifeddine M, Kawabata A, and Hollenberg MD. Proteinase activated receptor 2: role of extracellular loop 2 for ligand-mediated activation. Br J Pharmacol 128: 1105-1113, 1999.
5. Algermissen B, Sitzmann J, Nurnberg W, Laubscher JC, Henz BM, and Bauer F. Distribution and potential biologic function of the thrombin receptor PAR-1 on human keratinocytes. Arch Dermatol Res 292: 488-495, 2000.
6. Alm AK, Gagnemo-Persson R, Sorsa T, and Sundelin J. Extrapancreatic trypsin-2 cleaves proteinase-activated receptor-2. Biochem Biophys Res Commun 275: 77-83, 2000.
7. Andersen H, Greenberg DL, Fujikawa K, Xu W, Chung DW, and Davie EW. Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity. Proc Natl Acad Sci USA 96: 11189-11193, 1999.
8. Andrade-Gordon P, Derian CK, Maryanoff BE, Zhang HC, Addo MF, Cheung W, Damiano BP, D'Andrea MR, Darrow AL, de Garavilla L, Eckardt AJ, Giardino EC, Haertlein BJ, and McComsey DF. Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats. J Pharmacol Exp Ther 298: 34-42, 2001.
9. Andrade-Gordon P, Maryanoff BE, Derian CK, Zhang HC, Addo MF, Darrow AL, Eckardt AJ, Hoekstra WJ, McComsey DF, Oksenberg D, Reynolds EE, Santulli RJ, Scarborough RM, Smith CE, and White KB. Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor. Proc Natl Acad Sci USA 96: 12257-12262, 1999.
10. Aragay AM, Collins LR, Post GR, Watson AJ, Feramisco JR, Brown JH, and Simon MI. G12 requirement for thrombin-stimulated gene expression and DNA synthesis in 1321N1 astrocytoma cells. J Biol Chem 270: 20073-20077, 1995.
11. Asfaha S, Brussee V, Chapman K, Zochodne DW, and Vergnolle N. Proteinase-activated receptor-1 agonists attenuate nociception in response to noxious stimuli. Br J Pharmacol 135: 1101-1106, 2002.
12. 2 release from human respiratory epithelial cells. J Immunol 168: 3577-3585, 2002.
13. Baffy G, Yang L, Raj S, Manning DR, and Williamson JR. G protein coupling to the thrombin receptor in Chinese hamster lung fibroblasts. J Biol Chem 269: 8483-8487, 1994.
14. Beecher KL, Andersen TT, Fenton JWN, and Festoff BW. Thrombin receptor peptides induce shape change in neonatal murine astrocytes in culture. J Neurosci Res 37: 108-115, 1994.
15. Belham CM, Tate RJ, Scott PH, Pemberton AD, Miller HR, Wadsworth RM, Gould GW, and Plevin R. Trypsin stimulates proteinase-activated receptor-2-dependent and -independent activation of mitogen-activated protein kinases. Biochem J 320: 939-946, 1996.
16. Benka ML, Lee M, Wang GR, Buckman S, Burlacu A, Cole L, DePina A, Dias P, Granger A, Grant B, Hayward-Lester A, Karki S, Mann S, Marcu O, Nussenzweig A, Piepenhagen P, Raje M, Roegiers F, Rybak S, Salic A, Smith-Hall J, Waters J, Yamamoto N, Yanowitz J, Yeow K, Busa WB, and Mendelsohn ME. The thrombin receptor in human platelets is coupled to a GTP binding protein of the G alpha q family. FEBS Lett 363: 49-52, 1995.
17. Berger P, Compton SJ, Molimard M, Walls AF, N'Guyen C, Marthan R, and Tunon-De-Lara JM. Mast cell tryptase as a mediator of hyperresponsiveness in human isolated bronchi. Clin Exp Allergy 29: 804-812, 1999.
18. Berger P, Perng DW, Thabrew H, Compton SJ, Cairns JA, McEuen AR, Marthan R, Tunon De Lara JM, and Walls AF. Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells. J Appl Physiol 91: 1372-1379, 2001.
19. 2+ signaling in human airway smooth muscle cells. J Appl Physiol 91: 995-1003, 2001.
20. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, and Fisher CJ Jr. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699-709, 2001.
21. Blackhart BD, Emilsson K, Nguyen D, Teng W, Martelli AJ, Nystedt S, Sundelin J, and Scarborough RM. Ligand cross-reactivity within the protease-activated receptor family. J Biol Chem 271: 16466-16471, 1996.
22. Bohm SK, Grady EF, and Bunnett NW. Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochem J 322: 1-18, 1997.
23. Bohm SK, Khitin LM, Grady EF, Aponte G, Payan DG, and Bunnett NW. Mechanisms of desensitization and resensitization of proteinase-activated receptor-2. J Biol Chem 271: 22003-22016, 1996.
24. Bohm SK, Kong W, Bromme D, Smeekens SP, Anderson DC, Connolly A, Kahn M, Nelken NA, Coughlin SR, Payan DG, and Bunnett NW. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem J 314: 1009-1016, 1996.
25. Bouton MC, Jandrot-Perrus M, Moog S, Cazenave JP, Guillin MC, and Lanza F. Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system. Biochem J 305: 635-641, 1995.
26. Brass LF, Pizarro S, Ahuja M, Belmonte E, Blanchard N, Stadel JM, and Hoxie JA. Changes in the structure and function of the human thrombin receptor during receptor activation, internalization, and recycling. J Biol Chem 269: 2943-2952, 1994.
27. Bretschneider E, Kaufmann R, Braun M, Nowak G, Glusa E, and Schror K. Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells. Br J Pharmacol 132: 1441-1446, 2001.
28. Bretschneider E, Kaufmann R, Braun M, Wittpoth M, Glusa E, Nowak G, and Schror K. Evidence for proteinase-activated receptor-2 (PAR-2)-mediated mitogenesis in coronary artery smooth muscle cells. Br J Pharmacol 126: 1735-1740, 1999.
29. Brown JK, Tyler CL, Jones CA, Ruoss SJ, Hartmann T, and Caughey GH. Tryptase, the dominant secretory granular protein in human mast cells, is a potent mitogen for cultured dog tracheal smooth muscle cells. J Clin Invest 88: 493-499, 1991.
30. Buresi MC, Buret AG, Hollenberg MD, and MacNaughton WK. Activation of proteinase-activated receptor 1 stimulates epithelial chloride secretion through a unique MAP kinase- and cyclo-oxygenase-dependent pathway. FASEB J 16: 1515-1525, 2002.
31. - secretion in human intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 281: G323-G332, 2001.
32. Bustos D, Negri G, De Paula JA, Di Carlo M, Yapur V, Facente A, and De Paula A. Colonic proteinases: increased activity in patients with ulcerative colitis. Medicina 58: 262-264, 1998.
33. Cairns JA and Walls AF. Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J Immunol 156: 275-283, 1996.
34. Camerer E, Huang W, and Coughlin SR. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci USA 97: 5255-5260, 2000.
35. Camerer E, Kataoka H, Kahn M, Lease K, and Coughlin SR. Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells. J Biol Chem 277: 16081-16087, 2002.
36. Carney DH, Mann R, Redin WR, Pernia SD, Berry D, Heggers JP, Hayward PG, Robson MC, Christie J, Annable C, Fenton JW II, and Glenn KC. Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides. J Clin Invest 89: 1469-1477, 1992.
37. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, and Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389: 816-824, 1997.
38. Caughey GH. Mast cell chymases and tryptases: phylogeny, family relations, and biogenesis. In: Mast Cell Proteases in Immunology and Biology, edited by Caughey GH. New York: Dekker, 1995, p. 305-329.
39. Cavanaugh KP, Gurwitz D, Cunningham DD, and Bradshaw RA. Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1. J Neurochem 54: 1735-1743, 1990.
40. Cenac N, Coelho AM, Nguyen C, Compton S, Andrade-Gordon P, MacNaughton WK, Wallace JL, Hollenberg MD, Bunnett NW, Garcia-Villar R, Bueno L, and Vergnolle N. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am J Pathol 161: 1903-1915, 2002.
41. Cenac N, Garcia-Villar R, Ferrier L, Larauche M, Vergnolle N, Bunnett NW, Coelho AM, Fioramonti J, and Bueno L. Proteinase-activated receptor-2-induced colonic inflammation in mice: possible involvement of afferent neurons, nitric oxide, and paracellular permeability. J Immunol 170: 4296-4300, 2003.
42. Chambers RC, Leoni P, Blanc-Brude OP, Wembridge DE, and Laurent GJ. Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. J Biol Chem 275: 35584-35591, 2000.
43. Chen J, Ishii M, Wang L, Ishii K, and Coughlin SR. Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. J Biol Chem 269: 16041-16045, 1994.
44. Chen X, Earley K, Luo W, Lin SH, and Schilling WP. Functional expression of a human thrombin receptor in Sf9 insect cells: evidence for an active tethered ligand. Biochem J 314: 603-611, 1996.
45. Chen YH, Pouyssegur J, Courtneidge SA, and Van Obberghen-Schilling E. Activation of Src family kinase activity by the G protein-coupled thrombin receptor in growth-responsive fibroblasts. J Biol Chem 269: 27372-27377, 1994.
46. Cheng T, Liu D, Griffin JH, Fernandez JA, Castellino F, Rosen ED, Fukudome K, and Zlokovic BV. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med 9: 338-342, 2003.
47. Cheung WM, Andrade-Gordon P, Derian CK, and Damiano BP. Receptor-activating peptides distinguish thrombin receptor (PAR-1) and protease activated receptor 2 (PAR-2) mediated hemodynamic responses in vivo. Can J Physiol Pharmacol 76: 16-25, 1998.
48. Cheung WM, D'Andrea MR, Andrade-Gordon P, and Damiano BP. Altered vascular injury responses in mice deficient in protease-activated receptor-1. Arterioscler Thromb Vasc Biol 19: 3014-3024, 1999.
49. Chow JM, Moffatt JD, and Cocks TM. Effect of protease-activated receptor (PAR)-1, -2 and -4-activating peptides, thrombin and trypsin in rat isolated airways. Br J Pharmacol 131: 1584-1591, 2000.
50. Cicala C. Protease activated receptor 2 and the cardiovascular system. Br J Pharmacol 135: 14-20, 2002.
51. Cicala C, Bucci M, De Dominicis G, Harriot P, Sorrentino L, and Cirino G. Bronchoconstrictor effect of thrombin and thrombin receptor activating peptide in guinea-pigs in vivo. Br J Pharmacol 126: 478-484, 1999.
52. Cicala C, Morello S, Santagada V, Caliendo G, Sorrentino L, and Cirino G. Pharmacological dissection of vascular effects caused by activation of protease-activated receptors 1 and 2 in anesthetized rats. FASEB J 15: 1433-1435, 2001.
53. Cicala C, Pinto A, Bucci M, Sorrentino R, Walker B, Harriot P, Cruchley A, Kapas S, Howells GL, and Cirino G. Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo. Circulation 99: 2590-2597, 1999.
54. Cirino G, Bucci M, Cicala C, and Napoli C. Inflammation-coagulation network: are serine protease receptors the knot? Trends Pharmacol Sci 21: 170-172, 2000.
55. Clark JM, Abraham WM, Fishman CE, Forteza R, Ahmed A, Cortes A, Warne RL, Moore WR, and Tanaka RD. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. Am J Respir Crit Care Med 152: 2076-2083, 1995.
56. Cocks TM, Fong B, Chow JM, Anderson GP, Frauman AG, Goldie RG, Henry PJ, Carr MJ, Hamilton JR, and Moffatt JD. A protective role for protease-activated receptors in the airways. Nature 398: 156-160, 1999.
57. Cocks TM and Moffatt JD. Protease-activated receptors: sentries for inflammation? Trends Pharmacol Sci 21: 103-108, 2000.
58. Cocks TM and Moffatt JD. Protease-activated receptor-2 (PAR2) in the airways. Pulm Pharmacol Ther 14: 183-191, 2001.
59. Cocks TM, Sozzi V, Moffatt JD, and Selemidis S. Protease-activated receptors mediate apamin-sensitive relaxation of mouse and guinea pig gastrointestinal smooth muscle. Gastroenterology 116: 586-592, 1999.
60. Coelho AM, Vergnolle N, Guiard B, Fioramonti J, and Bueno L. Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats. Gastroenterology 122: 1035-1047, 2002.
61. Compton SJ, Cairns JA, Palmer KJ, Al-Ani B, Hollenberg MD, and Walls AF. A polymorphic protease-activated receptor 2 (PAR2) displaying reduced sensitivity to trypsin and differential responses to PAR agonists. J Biol Chem 275: 39207-39212, 2000.
62. Compton SJ, Renaux B, Wijesuriya SJ, and Hollenberg MD. Glycosylation and the activation of proteinase-activated receptor 2 [PAR(2)] by human mast cell tryptase. Br J Pharmacol 134: 705-718, 2001.
63. Compton SJ, Sandhu S, Wijesuriya SJ, and Hollenberg MD. Glycosylation of human proteinase-activated receptor-2 (hPAR2): role in cell surface expression and signalling. Biochem J 368: 495-505, 2002.
64. Connolly AJ, Ishihara H, Kahn ML, Farese RV Jr, and Coughlin SR. Role of the thrombin receptor in development and evidence for a second receptor. Nature 381: 516-519, 1996.
65. Connolly AJ, Suh DY, Hunt TK, and Coughlin SR. Mice lacking the thrombin receptor, PAR1 , have normal skin wound healing. Am J Pathol 151: 1199-1204, 1997.
66. Corvera CU, Dery O, McConalogue K, Bohm SK, Khitin LM, Caughey GH, Payan DG, and Bunnett NW. Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2. J Clin Invest 100: 1383-1393, 1997.
67. Corvera CU, Dery O, McConalogue K, Gamp P, Thoma M, Al-Ani B, Caughey GH, Hollenberg MD, and Bunnett NW. Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2. J Physiol 517: 741-756, 1999.
68. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 407: 258-264, 2000.
69. Coughlin SR and Camerer E. PARticipation in inflammation. J Clin Invest 111: 25-27, 2003.
70. Covic L, Gresser AL, and Kuliopulos A. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Biochemistry 39: 5458-5467, 2000.
71. Covic L, Gresser AL, Talavera J, Swift S, and Kuliopulos A. Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides. Proc Natl Acad Sci USA 99: 643-648, 2002.
72. Covic L, Misra M, Badar J, Singh C, and Kuliopulos A. Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation. Nat Med 8: 1161-1165, 2002.
73. + absorption in the mouse distal colon. J Physiol 539: 209-222, 2002.
74. Cumashi A, Ansuini H, Celli N, De Blasi A, O'Brien PJ, Brass LF, and Molino M. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets. Thromb Haemostasis 85: 533-538, 2001.
75. Cunningham MA, Rondeau E, Chen X, Coughlin SR, Holdsworth SR, and Tipping PG. Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med 191: 455-462, 2000.
76. Daaka Y, Luttrell LM, Ahn S, Della Rocca GJ, Ferguson SS, Caron MG, and Lefkowitz RJ. Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase. J Biol Chem 273: 685-688, 1998.
77. Damiano BP, Cheung WM, Santulli RJ, Fung-Leung WP, Ngo K, Ye RD, Darrow AL, Derian CK, de Garavilla L, and Andrade-Gordon P. Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. J Pharmacol Exp Ther 288: 671-678, 1999.
78. Danahay H, Withey L, Poll CT, van de Graaf SF, and Bridges RJ. Protease-activated receptor-2-mediated inhibition of ion transport in human bronchial epithelial cells. Am J Physiol Cell Physiol 280: C1455-C1464, 2001.
79. D'Andrea MR, Derian CK, Leturcq D, Baker SM, Brunmark A, Ling P, Darrow AL, Santulli RJ, Brass LF, and Andrade-Gordon P. Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J Histochem Cytochem 46: 157-164, 1998.
80. D'Andrea MR, Derian CK, Santulli RJ, and Andrade-Gordon P. Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissues. Am J Pathol 158: 2031-2041, 2001.
81. Darmoul D, Gratio V, Devaud H, Lehy T, and Laburthe M. Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells. Am J Pathol 162: 1503-1513, 2003.
82. Darmoul D, Marie JC, Devaud H, Gratio V, and Laburthe M. Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2. Br J Cancer 85: 772-779, 2001.
83. Darrow AL, Fung-Leung WP, Ye RD, Santulli RJ, Cheung WM, Derian CK, Burns CL, Damiano BP, Zhou L, Keenan CM, Peterson PA, and Andrade-Gordon P. Biological consequences of thrombin receptor deficiency in mice. Thromb Haemostasis 76: 860-866, 1996.
84. De Candia E, Hall SW, Rutella S, Landolfi R, Andrews RK, and De Cristofaro R. Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets. J Biol Chem 276: 4692-4698, 2001.
85. Defea K, Schmidlin F, Dery O, Grady EF, and Bunnett NW. Mechanisms of initiation and termination of signalling by neuropeptide receptors: a comparison with the proteinase-activated receptors. Biochem Soc Trans 28: 419-426, 2000.
86. DeFea KA, Zalevsky J, Thoma MS, Dery O, Mullins RD, and Bunnett NW. Beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 148: 1267-1281, 2000.
87. De Garavilla L, Vergnolle N, Young SH, Ennes H, Steinhoff M, Ossovskaya VS, D'Andrea MR, Mayer EA, Wallace JL, Hollenberg MD, Andrade-Gordon P, and Bunnett NW. Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism. Br J Pharmacol 133: 975-987, 2001.
88. Derian CK, Damiano BP, Addo MF, Darrow AL, D'Andrea MR, Nedelman M, Zhang HC, Maryanoff BE, and Andrade-Gordon P. Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates. J Pharmacol Exp Ther 304: 855-861, 2003.
89. Dery O, Corvera CU, Steinhoff M, and Bunnett NW. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol Cell Physiol 274: C1429-C1452, 1998.
90. Dery O, Thoma MS, Wong H, Grady EF, and Bunnett NW. Trafficking of proteinase-activated receptor-2 and beta-arrestin-1 tagged with green fluorescent protein. beta-Arrestin-dependent endocytosis of a proteinase receptor. J Biol Chem 274: 18524-18535, 1999.
91. Dihanich M, Kaser M, Reinhard E, Cunningham D, and Monard D. Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6: 575-581, 1991.
92. Donovan FM and Cunningham DD. Signaling pathways involved in thrombin-induced cell protection. J Biol Chem 273: 12746-12752, 1998.
93. Donovan FM, Pike CJ, Cotman CW, and Cunningham DD. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci 17: 5316-5326, 1997.
94. Ducroc R, Bontemps C, Marazova K, Devaud H, Darmoul D, and Laburthe M. Trypsin is produced by and activates protease-activated receptor-2 in human cancer colon cells: evidence for new autocrine loop. Life Sci 70: 1359-1367, 2002.
95. Dulon S, Cande C, Bunnett NW, Hollenberg MD, Chignard M, and Pidard D. Proteinase-activated receptor-2 and human lung epithelial cells: disarming by neutrophil serine proteinases. Am J Respir Cell Mol Biol 28: 339-346, 2003.
96. Ekholm IE, Brattsand M, and Egelrud T. Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process? J Invest Dermatol 114: 56-63, 2000.
97. Even-Ram S, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M, Ginzburg Y, Reich R, Vlodavsky I, and Bar-Shavit R. Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med 4: 909-914, 1998.
98. Faruqi TR, Weiss EJ, Shapiro MJ, Huang W, and Coughlin SR. Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function. J Biol Chem 275: 19728-19734, 2000.
99. Fee JA, Monsey JD, Handler RJ, Leonis MA, Mullaney SR, Hope HM, and Silbert DF. A Chinese hamster fibroblast mutant defective in thrombin-induced signaling has a low level of phospholipase C-beta 1. J Biol Chem 269: 21699-21708, 1994.
100. Feng DM, Veber DF, Connolly TM, Condra C, Tang MJ, and Nutt RF. Development of a potent thrombin receptor ligand. J Med Chem 38: 4125-4130, 1995.
101. Ferrell WR, Lockhart JC, Kelso EB, Dunning L, Plevin R, Meek SE, Smith AJ, Hunter GD, McLean JS, McGarry F, Ramage R, Jiang L, Kanke T, and Kawagoe J. Essential role for proteinase-activated receptor-2 in arthritis. J Clin Invest 111: 35-41, 2003.
102. Festoff BW, Smirnova IV, Ma J, and Citron BA. Thrombin, its receptor and protease nexin I, its potent serpin, in the nervous system. Semin Thromb Hemost 22: 267-271, 1996.
103. Fiorucci S, Mencarelli A, Palazzetti B, Distrutti E, Vergnolle N, Hollenberg MD, Wallace JL, Morelli A, and Cirino G. Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci USA 98: 13936-13941, 2001.
104. Gao C, Liu S, Hu HZ, Gao N, Kim GY, Xia Y, and Wood JD. Serine proteases excite myenteric neurons through protease-activated receptors in guinea pig small intestine. Gastroenterology 123: 1554-1564, 2002.
105. Gerszten RE, Chen J, Ishii M, Ishii K, Wang L, Nanevicz T, Turck CW, Vu TK, and Coughlin SR. Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface. Nature 368: 648-651, 1994.
106. Gill JS, Pitts K, Rusnak FM, Owen WG, and Windebank AJ. Thrombin induced inhibition of neurite outgrowth from dorsal root ganglion neurons. Brain Res 797: 321-327, 1998.
107. Gingrich MB, Junge CE, Lyuboslavsky P, and Traynelis SF. Potentiation of NMDA receptor function by the serine protease thrombin. J Neurosci 20: 4582-4595, 2000.
108. Grand RJ, Turnell AS, and Grabham PW. Cellular consequences of thrombin-receptor activation. Biochem J 313: 353-368, 1996.
109. Green BT, Bunnett NW, Kulkarni-Narla A, Steinhoff M, and Brown DR. Intestinal type 2 proteinase-activated receptors: expression in opioid-sensitive secretomotor neural circuits that mediate epithelial ion transport. J Pharmacol Exp Ther 295: 410-416, 2000.
110. Griffin CT, Srinivasan Y, Zheng YW, Huang W, and Coughlin SR. A role for thrombin receptor signaling in endothelial cells during embryonic development. Science 293: 1666-1670, 2001.
111. Griffin JH, Zlokovic B, and Fernandez JA. Activated protein C: potential therapy for severe sepsis, thrombosis, and stroke. Semin Hematol 39: 197-205, 2002.
112. Gurwitz D and Cunningham DD. Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc Natl Acad Sci USA 85: 3440-3444, 1988.
113. Hamilton JR, Chow JM, and Cocks TM. Protease-activated receptor-2 turnover stimulated independently of receptor activation in porcine coronary endothelial cells. Br J Pharmacol 127: 617-622, 1999.
114. Hamilton JR and Cocks TM. Heterogeneous mechanisms of endothelium-dependent relaxation for thrombin and peptide activators of protease-activated receptor-1 in porcine isolated coronary artery. Br J Pharmacol 130: 181-188, 2000.
115. Hamilton JR, Frauman AG, and Cocks TM. Increased expression of protease-activated receptor-2 (par2) and par4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to par2 and par4 agonists. Circ Res 89: 92-98, 2001.
116. Hamilton JR, Moffatt JD, Frauman AG, and Cocks TM. Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries. J Cardiovasc Pharmacol 38: 108-119, 2001.
117. Hamilton JR, Moffatt JD, Tatoulis J, and Cocks TM. Enzymatic activation of endothelial protease-activated receptors is dependent on artery diameter in human and porcine isolated coronary arteries. Br J Pharmacol 136: 492-501, 2002.
118. Hayes KL and Tracy PB. The platelet high affinity binding site for thrombin mimics hirudin, modulates thrombin-induced platelet activation, and is distinct from the glycoprotein Ib-IX-V complex. J Biol Chem 274: 972-980, 1999.
119. He S, Peng Q, and Walls AF. Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine. J Immunol 159: 6216-6225, 1997.
120. He S and Walls AF. Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation. Eur J Pharmacol 328: 89-97, 1997.
121. Hein L, Ishii K, Coughlin SR, and Kobilka BK. Intracellular targeting and trafficking of thrombin receptors. A novel mechanism for resensitization of a G protein-coupled receptor. J Biol Chem 269: 27719-27726, 1994.
122. Henrikson KP, Salazar SL, Fenton JW II, and Pentecost BT. Role of thrombin receptor in breast cancer invasiveness. Br J Cancer 79: 401-406, 1999.
123. Hollenberg MD, Saifeddine M, al-Ani B, and Kawabata A. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can J Physiol Pharmacol 75: 832-841, 1997.
124. Hoogerwerf WA, Zou L, Shenoy M, Sun D, Micci MA, Lee-Hellmich H, Xiao SY, Winston JH, and Pasricha PJ. The proteinase-activated receptor 2 is involved in nociception. J Neurosci 21: 9036-9042, 2001.
125. Horvat R and Palade GE. The functional thrombin receptor is associated with the plasmalemma and a large endosomal network in cultured human umbilical vein endothelial cells. J Cell Sci 108: 1155-1164, 1995.
126. Hou L, Kapas S, Cruchley AT, Macey MG, Harriott P, Chinni C, Stone SR, and Howells GL. Immunolocalization of protease-activated receptor-2 in skin: receptor activation stimulates interleukin-8 secretion by keratinocytes in vitro. Immunology 94: 356-362, 1998.
127. Howell DC, Laurent GJ, and Chambers RC. Role of thrombin and its major cellular receptor, protease-activated receptor-1, in pulmonary fibrosis. Biochem Soc Trans 30: 211-216, 2002.
128. Howells GL, Macey MG, Chinni C, Hou L, Fox MT, Harriott P, and Stone SR. Proteinase-activated receptor-2: expression by human neutrophils. J Cell Sci 110: 881-887, 1997.
129. Hoxie JA, Ahuja M, Belmonte E, Pizarro S, Parton R, and Brass LF. Internalization and recycling of activated thrombin receptors. J Biol Chem 268: 13756-13763, 1993.
130. Huang C, De Sanctis GT, O'Brien PJ, Mizgerd JP, Friend DS, Drazen JM, Brass LF, and Stevens RL. Evaluation of the substrate specificity of human mast cell tryptase beta I and demonstration of its importance in bacterial infections of the lung. J Biol Chem 276: 26276-26284, 2001.
131. Hung DT, Vu TH, Nelken NA, and Coughlin SR. Thrombin-induced events in non-platelet cells are mediated by the unique proteolytic mechanism established for the cloned platelet thrombin receptor. J Cell Biol 116: 827-832, 1992.
132. Hung DT, Wong YH, Vu TK, and Coughlin SR. The cloned platelet thrombin receptor couples to at least two distinct effectors to stimulate phosphoinositide hydrolysis and inhibit adenylyl cyclase. J Biol Chem 267: 20831-20834, 1992.
133. Iaccarino G, Rockman HA, Shotwell KF, Tomhave ED, and Koch WJ. Myocardial overexpression of GRK3 in transgenic mice: evidence for in vivo selectivity of GRKs. Am J Physiol Heart Circ Physiol 275: H1298-H1306, 1998.
134. Idell S, Gonzalez K, Bradford H, MacArthur CK, Fein AM, Maunder RJ, Garcia JG, Griffith DE, Weiland J, and Martin TR. Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII. Am Rev Respir Dis 136: 1466-1474, 1987.
135. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T, and Coughlin SR. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386: 502-506, 1997.
136. Ishii K, Chen J, Ishii M, Koch WJ, Freedman NJ, Lefkowitz RJ, and Coughlin SR. Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase. Functional specificity among G-protein coupled receptor kinases. J Biol Chem 269: 1125-1130, 1994.
137. Ishii K, Hein L, Kobilka B, and Coughlin SR. Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling. J Biol Chem 268: 9780-9786, 1993.
138. Jalink K, van Corven EJ, Hengeveld T, Morii N, Narumiya S, and Moolenaar WH. Inhibition of lysophosphatidate- and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho. J Cell Biol 126: 801-810, 1994.
139. Jarjour NN, Calhoun WJ, Schwartz LB, and Busse WW. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction. Am Rev Respir Dis 144: 83-87, 1991.
140. Jin E, Fujiwara M, Pan X, Ghazizadeh M, Arai S, Ohaki Y, Kajiwara K, Takemura T, and Kawanami O. Protease-activated receptor (PAR)-1 and PAR-2 participate in the cell growth of alveolar capillary endothelium in primary lung adenocarcinomas. Cancer 97: 703-713, 2003.
141. Julius D and Basbaum AI. Molecular mechanisms of nociception. Nature 413: 203-210, 2001.
142. Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, and Coughlin SR. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 103: 879-887, 1999.
143. Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, Farese RV Jr, Tam C, and Coughlin SR. A dual thrombin receptor system for platelet activation. Nature 394: 690-694, 1998.
144. Kamath L, Meydani A, Foss F, and Kuliopulos A. Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells. Cancer Res 61: 5933-5940, 2001.
145. Kanke T, Macfarlane SR, Seatter MJ, Davenport E, Paul A, McKenzie R, and Plevin R. Proteinase-activated receptor-2-mediated activation of stress-activated protein kinases and inhibitory kappa B kinases in NCTC 2544 keratinocytes. J Biol Chem 18: 18, 2001.
146. Katona G, Berglund GI, Hajdu J, Graf L, and Szilagyi L. Crystal structure reveals basis for the inhibitor resistance of human brain trypsin. J Mol Biol 315: 1209-1218, 2002.
147. Kauffman HF, Tomee JF, van de Riet MA, Timmerman AJ, and Borger P. Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 105: 1185-1193, 2000.
148. Kaufmann R, Patt S, Zieger M, Kraft R, Tausch S, Henklein P, and Nowak G.
149. Kawabata A, Kawao N, Kuroda R, Itoh H, and Nishikawa H. Specific expression of spinal Fos after PAR-2 stimulation in most cell-depleted rats. Neuroreport 13: 511-514, 2002.
150. Kawabata A, Kawao N, Kuroda R, Tanaka A, Itoh H, and Nishikawa H. Peripheral PAR-2 triggers thermal hyperalgesia and nociceptive responses in rats. Neuroreport 12: 715-719, 2001.
151. Kawabata A, Kawao N, Kuroda R, Tanaka A, and Shimada C. The PAR-1-activating peptide attenuates carrageenan-induced hyperalgesia in rats. Peptides 23: 1181-1183, 2002.
152. Kawabata A, Kinoshita M, Kuroda R, and Kakehi K. Capsazepine partially inhibits neurally mediated gastric mucus secretion following activation of protease-activated receptor 2. Clin Exp Pharmacol Physiol 29: 360-361, 2002.
153. Kawabata A, Kinoshita M, Nishikawa H, Kuroda R, Nishida M, Araki H, Arizono N, Oda Y, and Kakehi K. The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection. J Clin Invest 107: 1443-1450, 2001.
154. Kawabata A, Kuroda R, Kuroki N, Nishikawa H, and Kawai K. Dual modulation by thrombin of the motility of rat oesophageal muscularis mucosae via two distinct protease-activated receptors (PARs): a novel role for PAR-4 as opposed to PAR-1. Br J Pharmacol 131: 578-584, 2000.
155. Kawabata A, Kuroda R, Nagata N, Kawao N, Masuko T, Nishikawa H, and Kawai K. In vivo evidence that protease-activated receptors 1 and 2 modulate gastrointestinal transit in the mouse. Br J Pharmacol 133: 1213-1218, 2001.
156. Kawabata A, Kuroda R, Nishida M, Nagata N, Sakaguchi Y, Kawao N, Nishikawa H, Arizono N, and Kawai K. Protease-activated receptor-2 (PAR-2) in the pancreas and parotid gland: immunolocalization and involvement of nitric oxide in the evoked amylase secretion. Life Sci 71: 2435-2446, 2002.
157. Kawabata A, Morimoto N, Nishikawa H, Kuroda R, Oda Y, and Kakehi K. Activation of protease-activated receptor-2 (PAR-2) triggers mucin secretion in the rat sublingual gland. Biochem Biophys Res Commun 270: 298-302, 2000.
158. Kawabata A, Nishikawa H, Kuroda R, Kawai K, and Hollenberg MD. Proteinase-activated receptor-2 (PAR-2): regulation of salivary and pancreatic exocrine secretion in vivo in rats and mice. Br J Pharmacol 129: 1808-1814, 2000.
159. Kawagoe J, Takizawa T, Matsumoto J, Tamiya M, Meek SE, Smith AJ, Hunter GD, Plevin R, Saito N, Kanke T, Fujii M, and Wada Y. Effect of protease-activated receptor-2 deficiency on allergic dermatitis in the mouse ear. Jpn J Pharmacol 88: 77-84, 2002.
160. Kawao N, Sakaguchi Y, Tagome A, Kuroda R, Nishida S, Irimajiri K, Nishikawa H, Kawai K, Hollenberg MD, and Kawabata A. Proteose-activated receptor-2 (PAR-2) in the rat gastric mucosa: immunolocalization and facilitation of pepsin/pepsinogen secretion. Br J Pharmacol 135: 1292-1296, 2002.
161. Keogh RJ, Houliston RA, and Wheeler-Jones CP. Thrombin-stimulated Pyk2 phosphorylation in human endothelium is dependent on intracellular calcium and independent of protein kinase C and Src kinases. Biochem Biophys Res Commun 294: 1001-1008, 2002.
162. King C, Brennan S, Thompson PJ, and Stewart GA. Dust mite proteolytic allergens induce cytokine release from cultured airway epithelium. J Immunol 161: 3645-3651, 1998.
163. Klages B, Brandt U, Simon MI, Schultz G, and Offermanns S. Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets. J Cell Biol 144: 745-754, 1999.
164. Knight DA, Lim S, Scaffidi AK, Roche N, Chung KF, Stewart GA, and Thompson PJ. Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma. J Allergy Clin Immunol 108: 797-803, 2001.
165. Koivunen E, Huhtala ML, and Stenman UH. Human ovarian tumor-associated trypsin. Its purification and characterization from mucinous cyst fluid and identification as an activator of pro-urokinase. J Biol Chem 264: 14095-14099, 1989.
166. Koivunen E, Saksela O, Itkonen O, Osman S, Huhtala ML, and Stenman UH. Human colonic carcinoma, fibrosarcoma and leukemia cell lines produce tumor-associated trypsinogen. Int J Cancer 47: 592-596, 1991.
167. Kong W, McConalogue K, Khitin LM, Hollenberg MD, Payan DG, Bohm SK, and Bunnett NW. Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. Proc Natl Acad Sci USA 94: 8884-8889, 1997.
168. Koshikawa N, Hasegawa S, Nagashima Y, Mitsuhashi K, Tsubota Y, Miyata S, Miyagi Y, Yasumitsu H, and Miyazaki K. Expression of trypsin by epithelial cells of various tissues, leukocytes, and neurons in human and mouse. Am J Pathol 153: 937-944, 1998.
169. Koshikawa N, Nagashima Y, Miyagi Y, Mizushima H, Yanoma S, Yasumitsu H, and Miyazaki K. Expression of trypsin in vascular endothelial cells. FEBS Lett 409: 442-448, 1997.
170. Krishna MT, Chauhan A, Little L, Sampson K, Hawksworth R, Mant T, Djukanovic R, Lee T, and Holgate S. Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma. J Allergy Clin Immunol 107: 1039-1045, 2001.
171. Kunzelmann K, Schreiber R, Konig J, and Mall M. Ion transport induced by proteinase-activated receptors (PAR2) in colon and airways. Cell Biochem Biophys 36: 209-214, 2002.
172. Lan RS, Knight DA, Stewart GA, and Henry PJ. Role of PGE(2) in protease-activated receptor-1, -2 and -4 mediated relaxation in the mouse isolated trachea. Br J Pharmacol 132: 93-100, 2001.
173. Lan RS, Stewart GA, and Henry PJ. Modulation of airway smooth muscle tone by protease activated receptor- 1,-2,-3 and -4 in trachea isolated from influenza A virus-infected mice. Br J Pharmacol 129: 63-70, 2000.
174. Laposata M, Dovnarsky DK, and Shin HS. Thrombin-induced gap formation in confluent endothelial cell monolayers in vitro. Blood 62: 549-556, 1983.
175. Lerner DJ, Chen M, Tram T, and Coughlin SR. Agonist recognition by proteinase-activated receptor 2 and thrombin receptor. Importance of extracellular loop interactions for receptor function. J Biol Chem 271: 13943-13947, 1996.
176. Linden DR, Manning BP, Bunnett NW, and Mawe GM. Agonists of proteinase-activated receptor 2 excite guinea pig ileal myenteric neurons. Eur J Pharmacol 431: 311-314, 2001.
177. Lindner JR, Kahn ML, Coughlin SR, Sambrano GR, Schauble E, Bernstein D, Foy D, Hafezi-Moghadam A, and Ley K. Delayed onset of inflammation in protease-activated receptor-2-deficient mice. J Immunol 165: 6504-6510, 2000.
178. Lourbakos A, Chinni C, Thompson P, Potempa J, Travis J, Mackie EJ, and Pike RN. Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett 435: 45-48, 1998.
179. Lourbakos A, Potempa J, Travis J, D'Andrea MR, Andrade-Gordon P, Santulli R, Mackie EJ, and Pike RN. Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect Immun 69: 5121-5130, 2001.
180. Lourbakos A, Yuan YP, Jenkins AL, Travis J, Andrade-Gordon P, Santulli R, Potempa J, and Pike RN. Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood 97: 3790-3797, 2001.
181. Luttrell LM and Lefkowitz RJ. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 115: 455-465, 2002.
182. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, and Plevin R. Proteinase-activated receptors. Pharmacol Rev 53: 245-282, 2001.
183. Madamanchi NR, Li S, Patterson C, and Runge MS. Thrombin regulates vascular smooth muscle cell growth and heat shock proteins via the JAK-STAT pathway. J Biol Chem 276: 18915-18924, 2001.
184. Magazine HI, King JM, and Srivastava KD. Protease activated receptors modulate aortic vascular tone. Int J Cardiol 53 Suppl: S75-S80, 1996.
185. Marchese A and Benovic JL. Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting. J Biol Chem 276: 45509-45512, 2001.
186. Marty I, Peclat V, Kirdaite G, Salvi R, So A, and Busso N. Amelioration of collagen-induced arthritis by thrombin inhibition. J Clin Invest 107: 631-640, 2001.
187. Maryanoff BE, Santulli RJ, McComsey DF, Hoekstra WJ, Hoey K, Smith CE, Addo M, Darrow AL, and Andrade-Gordon P. Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes. Arch Biochem Biophys 386: 195-204, 2001.
188. McEuen AR, He S, Brander ML, and Walls AF. Guinea pig lung tryptase. Localisation to mast cells and characterisation of the partially purified enzyme. Biochem Pharmacol 52: 331-340, 1996.
189. McNamara CA, Sarembock IJ, Gimple LW, Fenton JW, Coughlin SR, and Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest 91: 94-98, 1993.
190. Metcalfe DD, Baram D, and Mekori YA. Mast cells. Physiol Rev 77: 1033-1079, 1997.
191. Milia AF, Salis MB, Stacca T, Pinna A, Madeddu P, Trevisani M, Geppetti P, and Emanueli C. Protease-activated receptor-2 stimulates angiogenesis and accelerates hemodynamic recovery in a mouse model of hindlimb ischemia. Circ Res 91: 346-352, 2002.
192. Miotto D, Hollenberg MD, Bunnett NW, Papi A, Braccioni F, Boschetto P, Rea F, Zuin A, Geppetti P, Saetta M, Maestrelli P, Fabbri LM, and Mapp CE. Expression of protease activated receptor-2 (PAR-2) in central airways of smokers and non-smokers. Thorax 57: 146-151, 2002.
193. Mirza H, Schmidt VA, Derian CK, Jesty J, and Bahou WF. Mitogenic responses mediated through the proteinase-activated receptor-2 are induced by expressed forms of mast cell alpha- or beta-tryptases. Blood 90: 3914-3922, 1997.
194. Mirza H, Yatsula V, and Bahou WF. The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells. J Clin Invest 97: 1705-1714, 1996.
195. Moffatt JD, Jeffrey KL, and Cocks TM. Protease-activated receptor-2 activating peptide SLIGRL inhibits bacterial lipopolysaccharide-induced recruitment of polymorphonuclear leukocytes into the airways of mice. Am J Respir Cell Mol Biol 26: 680-684, 2002.
196. Molino M, Barnathan ES, Numerof R, Clark J, Dreyer M, Cumashi A, Hoxie JA, Schechter N, Woolkalis M, and Brass LF. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 272: 4043-4049, 1997.
197. Molino M, Blanchard N, Belmonte E, Tarver AP, Abrams C, Hoxie JA, Cerletti C, and Brass LF. Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G. J Biol Chem 270: 11168-11175, 1995.
198. Mule F, Baffi MC, and Cerra MC. Dual effect mediated by protease-activated receptors on the mechanical activity of rat colon. Br J Pharmacol 136: 367-374, 2002.
199. Nakanishi-Matsui M, Zheng YW, Sulciner DJ, Weiss EJ, Ludeman MJ, and Coughlin SR. PAR3 is a cofactor for PAR4 activation by thrombin. Nature 404: 609-613, 2000.
200. Nakayama T, Hirano K, Shintani Y, Nishimura J, Nakatsuka A, Kuga H, Takahashi S, and Kanaide H. Unproductive cleavage and the inactivation of protease-activated receptor-1 by trypsin in vascular endothelial cells. Br J Pharmacol 138: 121-130, 2003.
201. Nanevicz T, Ishii M, Wang L, Chen M, Chen J, Turck CW, Cohen FE, and Coughlin SR. Mechanisms of thrombin receptor agonist specificity. Chimeric receptors and complementary mutations identify an agonist recognition site. J Biol Chem 270: 21619-21625, 1995.
202. Nanevicz T, Wang L, Chen M, Ishii M, and Coughlin SR. Thrombin receptor activating mutations. Alteration of an extracellular agonist recognition domain causes constitutive signaling. J Biol Chem 271: 702-706, 1996.
203. Napoli C, Cicala C, Wallace JL, de Nigris F, Santagada V, Caliendo G, Franconi F, Ignarro LJ, and Cirino G. Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart. Proc Natl Acad Sci USA 97: 3678-3683, 2000.
204. Napoli C, De Nigris F, Cicala C, Wallace JL, Caliendo G, Condorelli M, Santagada V, and Cirino G. Protease-activated receptor-2 activation improves efficiency of experimental ischemic preconditioning. Am J Physiol Heart Circ Physiol 282: H2004-H2010, 2002.
205. Nguyen TD, Moody MW, Steinhoff M, Okolo C, Koh DS, and Bunnett NW. Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2. J Clin Invest 103: 261-269, 1999.
206. Niclou S, Suidan HS, Brown-Luedi M, and Monard D. Expression of the thrombin receptor mRNA in rat brain. Cell Mol Biol 40: 421-428, 1994.
207. Niclou SP, Suidan HS, Pavlik A, Vejsada R, and Monard D. Changes in the expression of protease-activated receptor 1 and protease nexin-1 mRNA during rat nervous system development and after nerve lesion. Eur J Neurosci 10: 1590-1607, 1998.
208. Nierodzik ML, Bain RM, Liu LX, Shivji M, Takeshita K, and Karpatkin S. Presence of the seven transmembrane thrombin receptor on human tumour cells: effect of activation on tumour adhesion to platelets and tumor tyrosine phosphorylation. Br J Haematol 92: 452-457, 1996.
209. Nierodzik ML, Chen K, Takeshita K, Li JJ, Huang YQ, Feng XS, D'Andrea MR, Andrade-Gordon P, and Karpatkin S. Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Blood 92: 3694-3700, 1998.
210. Nierodzik ML, Kajumo F, and Karpatkin S. Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Cancer Res 52: 3267-3272, 1992.
211. Nishikawa H, Kawai K, Nishimura S, Tanaka S, Araki H, Al-Ani B, Hollenberg MD, Kuroda R, and Kawabata A. Suppression by protease-activated receptor-2 activation of gastric acid secretion in rats. Eur J Pharmacol 447: 87-90, 2002.
212. Norton KJ, Scarborough RM, Kutok JL, Escobedo MA, Nannizzi L, and Coller BS. Immunologic analysis of the cloned platelet thrombin receptor activation mechanism: evidence supporting receptor cleavage, release of the N-terminal peptide, and insertion of the tethered ligand into a protected environment. Blood 82: 2125-2136, 1993.
213. Nystedt S, Emilsson K, Larsson AK, Strombeck B, and Sundelin J. Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur J Biochem. 232: 84-89, 1995.
214. Nystedt S, Emilsson K, Wahlestedt C, and Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 91: 9208-9212, 1994.
215. Nystedt S, Larsson AK, Aberg H, and Sundelin J. The mouse proteinase-activated receptor-2 cDNA and gene. Molecular cloning and functional expression. J Biol Chem 270: 5950-5955, 1995.
216. Nystedt S, Ramakrishnan V, and Sundelin J. The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J Biol Chem 271: 14910-14915, 1996.
217. O'Brien PJ, Molino M, Kahn M, and Brass LF. Protease activated receptors: theme and variations. Oncogene 20: 1570-1581, 2001.
218. O'Brien PJ, Prevost N, Molino M, Hollinger MK, Woolkalis MJ, Woulfe DS, and Brass LF. Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. J Biol Chem 275: 13502-13509, 2000.
219. Offermanns S. In vivo functions of heterotrimeric G-proteins: studies in Galpha-deficient mice. Oncogene 20: 1635-1642, 2001.
220. 2 and thrombin receptors in human platelets. Proc Natl Acad Sci USA 91: 504-508, 1994.
221. 13 deficiency. Science 275: 533-536, 1997.
222. Offermanns S, Toombs CF, Hu YH, and Simon MI. Defective platelet activation in G alpha(q)-deficient mice. Nature 389: 183-186, 1997.
223. Ofosu FA, Freedman J, Dewar L, Song Y, and Fenton JW II. A trypsin-like platelet protease propagates protease-activated receptor-1 cleavage and platelet activation. Biochem J 336: 283-285, 1998.
224. Paine C, Sharlow E, Liebel F, Eisinger M, Shapiro S, and Seiberg M. An alternative approach to depigmentation by soybean extracts via inhibition of the PAR-2 pathway. J Invest Dermatol 116: 587-595, 2001.
225. Paing MM, Stutts AB, Kohout TA, Lefkowitz RJ, and Trejo J. beta-Arrestins regulate protease-activated receptor-1 desensitization but not internalization or down-regulation. J Biol Chem 277: 1292-1300, 2002.
226. Patterson C, Stouffer GA, Madamanchi N, and Runge MS. New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology. Circ Res 88: 987-997, 2001.
227. Pendurthi UR, Ngyuen M, Andrade-Gordon P, Petersen LC, and Rao LV. Plasmin induces Cyr61 gene expression in fibroblasts via protease-activated receptor-1 and p44/42 mitogen-activated protein kinase-dependent signaling pathway. Arterioscler Thromb Vasc Biol 22: 1421-1426, 2002.
228. Pereira PJ, Bergner A, Macedo-Ribeiro S, Huber R, Matschiner G, Fritz H, Sommerhoff CP, and Bode W. Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. Nature 392: 306-311, 1998.
229. Perraud F, Besnard F, Sensenbrenner M, and Labourdette G. Thrombin is a potent mitogen for rat astroblasts but not for oligodendroblasts and neuroblasts in primary culture. Int J Dev Neurosci 5: 181-188, 1987.
230. Pindon A, Berry M, and Hantai D. Thrombomodulin as a new marker of lesion-induced astrogliosis: involvement of thrombin through the G-protein-coupled protease-activated receptor-1. J Neurosci 20: 2543-2550, 2000.
231. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, and Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402: 884-888, 1999.
232. Raithel M, Winterkamp S, Pacurar A, Ulrich P, Hochberger J, and Hahn EG. Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease. Scand J Gastroenterol 36: 174-179, 2001.
233. 2+ mobilization. FEBS Lett 288: 123-128, 1991.
234. Rattenholl A and Steinhoff M. Role of proteinase-activated receptors in cutaneous biology and disease. In: Drug Development Research, edited by M. Hollenberg and N. Vergrolle. New York: Wiley-Liss, 2003, vol. 59, p. 408-417.
235. Reed DE, Barajas-Lopez C, Cottrell G, Velazquez-Rocha S, Dery O, Grady EF, Bunnett NW, and Vanner SJ. Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea-pig submucosal neurons. J Physiol 547: 531-542, 2003.
236. Renesto P, Si-Tahar M, Moniatte M, Balloy V, Van Dorsselaer A, Pidard D, and Chignard M. Specific inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, cathepsin G, and proteinase 3: evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptor. Blood 89: 1944-1953, 1997.
237. Ricciardolo FL, Steinhoff M, Amadesi S, Guerrini R, Tognetto M, Trevisani M, Creminon C, Bertrand C, Bunnett NW, Fabbri LM, Salvadori S, and Geppetti P. Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways. Am J Respir Crit Care Med 161: 1672-1680, 2000.
238. Riewald M, Petrovan RJ, Donner A, Mueller BM, and Ruf W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296: 1880-1882, 2002.
239. Riewald M and Ruf W. Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc Natl Acad Sci USA 98: 7742-7747, 2001.
240. Riewald M and Ruf W. Science review: role of coagulation protease cascades in sepsis. Crit Care 7: 123-129, 2003.
241. Robin J, Kharbanda R, McLean P, Campbell R, and Vallance P. Protease-activated receptor 2-mediated vasodilatation in humans in vivo: role of nitric oxide and prostanoids. Circulation 107: 954-959, 2003.
242. Roosterman D, Schmidlin F, and Bunnett NW. Rab5a and rab11a mediate agonist-induced trafficking of protease-activated receptor 2. Am J Physiol Cell Physiol 284: C1319-C1329, 2003.
243. Roy SS, Saifeddine M, Loutzenhiser R, Triggle CR, and Hollenberg MD. Dual endothelium-dependent vascular activities of proteinase-activated receptor-2-activating peptides: evidence for receptor heterogeneity. Br J Pharmacol 123: 1434-1440, 1998.
244. Ruoss S, Hartmann T, and Caughey G. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 88: 493-499, 1991.
245. Sabri A, Alcott SG, Elouardighi H, Pak E, Derian C, Andrade-Gordon P, Kinnally K, and Steinberg SF. Neutrophil cathepsin G promotes detachment-induced cardiomyocyte apoptosis via a protease-activated receptor-independent mechanism. J Biol Chem. In press.
246. Sabri A, Short J, Guo J, and Steinberg SF. Protease-activated receptor-1-mediated DNA synthesis in cardiac fibroblast is via epidermal growth factor receptor transactivation: distinct PAR-1 signaling pathways in cardiac fibroblasts and cardiomyocytes. Circ Res 91: 532-539, 2002.
247. Saifeddine M, al-Ani B, Cheng CH, Wang L, and Hollenberg MD. Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. Br J Pharmacol 118: 521-530, 1996.
248. Saifeddine M, Roy SS, Al-Ani B, Triggle CR, and Hollenberg MD. Endothelium-dependent contractile actions of proteinase-activated receptor-2-activating peptides in human umbilical vein: release of a contracting factor via a novel receptor. Br J Pharmacol 125: 1445-1454, 1998.
249. Sambrano GR, Huang W, Faruqi T, Mahrus S, Craik C, and Coughlin SR. Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem 275: 6819-6823, 2000.
250. Santos J, Bayarri C, Saperas E, Nogueiras C, Antolin M, Mourelle M, Cadahia A, and Malagelada JR. Characterisation of immune mediator release during the immediate response to segmental mucosal challenge in the jejunum of patients with food allergy. Gut 45: 553-558, 1999.
251. Santulli RJ, Derian CK, Darrow AL, Tomko KA, Eckardt AJ, Seiberg M, Scarborough RM, and Andrade-Gordon P. Evidence for the presence of a protease-activated receptor distinct from the thrombin receptor in human keratinocytes. Proc Natl Acad Sci USA 92: 9151-9155, 1995.
252. Sawada K, Nishibori M, Nakaya N, Wang Z, and Saeki K. Purification and characterization of a trypsin-like serine proteinase from rat brain slices that degrades laminin and type IV collagen and stimulates protease-activated receptor-2. J Neurochem 74: 1731-1738, 2000.
253. Scarborough RM, Naughton MA, Teng W, Hung DT, Rose J, Vu TK, Wheaton VI, Turck CW, and Coughlin SR. Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J Biol Chem 267: 13146-13149, 1992.
254. Schechter NM, Brass LF, Lavker RM, and Jensen PJ. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts. J Cell Physiol 176: 365-373, 1998.
255. Schmidlin F, Amadesi S, Dabbagh K, Lewis DE, Knott P, Bunnett NW, Gater PR, Geppetti P, Bertrand C, and Stevens ME. Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J Immunol 169: 5315-5321, 2002.
256. Schmidlin F, Amadesi S, Vidil R, Trevisani M, Martinet N, Caughey G, Tognetto M, Cavallesco G, Mapp C, Geppetti P, and Bunnett NW. Expression and function of proteinase-activated receptor 2 in human bronchial smooth muscle. Am J Respir Crit Care Med 164: 1276-1281, 2001.
257. Scott G, Deng A, Rodriguez-Burford C, Seiberg M, Han R, Babiarz L, Grizzle W, Bell W, and Pentland A. Protease-activated receptor 2, a receptor involved in melanosome transfer, is upregulated in human skin by ultraviolet irradiation. J Invest Dermatol 117: 1412-1420, 2001.
258. Scudamore CL, Thornton EM, McMillan L, Newlands GF, and Miller HR. Release of the mucosal mast cell granule chymase, rat mast cell protease-II, during anaphylaxis is associated with the rapid development of paracellular permeability to macromolecules in rat jejunum. J Exp Med 182: 1871-1881, 1995.
259. Seiberg M, Paine C, Sharlow E, Andrade-Gordon P, Costanzo M, Eisinger M, and Shapiro SS. The protease-activated receptor 2 regulates pigmentation via keratinocyte-melanocyte interactions. Exp Cell Res 254: 25-32, 2000.
260. + exchange by a thrombin receptor antagonist. Biochem Pharmacol 49: 519-528, 1995.
261. Shapiro MJ and Coughlin SR. Separate signals for agonist-independent and agonist-triggered trafficking of protease-activated receptor 1. J Biol Chem 273: 29009-29014, 1998.
262. Shapiro MJ, Trejo J, Zeng D, and Coughlin SR. Role of the thrombin receptor's cytoplasmic tail in intracellular trafficking. Distinct determinants for agonist-triggered versus tonic internalization and intracellular localization. J Biol Chem 271: 32874-32880, 1996.
263. Shapiro MJ, Weiss EJ, Faruqi TR, and Coughlin SR. Protease-activated receptors 1 and 4 are shutoff with distinct kinetics after activation by thrombin. J Biol Chem 275: 25216-25221, 2000.
264. Sharlow ER, Paine CS, Babiarz L, Eisinger M, Shapiro S, and Seiberg M. The protease-activated receptor-2 upregulates keratinocyte phagocytosis. J Cell Sci 113: 3093-3101, 2000.
265. Smith-Swintosky VL, Cheo-Isaacs CT, D'Andrea MR, Santulli RJ, Darrow AL, and Andrade-Gordon P. Protease-activated receptor-2 (PAR-2) is present in the rat hippocampus and is associated with neurodegeneration. J Neurochem 69: 1890-1896, 1997.
266. Southan C. A genomic perspective on human proteases. FEBS Lett 498: 214-218, 2001.
267. Stead RH, Tomioka M, Quinonez G, Simon GT, Felten SY, and Bienenstock J. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci USA 84: 2975-2979, 1987.
268. Steinhoff M, Corvera CU, Thoma MS, Kong W, McAlpine BE, Caughey GH, Ansel JC, and Bunnett NW. Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase. Exp Dermatol 8: 282-294, 1999.
269. Steinhoff M, Neisius U, Ikoma A, Fartasch M, Heyer G, Skov PS, Luger TA, and Schmelz M. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci. In press.
270. Steinhoff M, Vergnolle N, Young SH, Tognetto M, Amadesi S, Ennes HS, Trevisani M, Hollenberg MD, Wallace JL, Caughey GH, Mitchell SE, Williams LM, Geppetti P, Mayer EA, and Bunnett NW. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 6: 151-158, 2000.
271. Striggow F, Riek M, Breder J, Henrich-Noack P, Reymann KG, and Reiser G. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc Natl Acad Sci USA 97: 2264-2269, 2000.
272. Suidan HS, Bouvier J, Schaerer E, Stone SR, Monard D, and Tschopp J. Granzyme A released upon stimulation of cytotoxic T lymphocytes activates the thrombin receptor on neuronal cells and astrocytes. Proc Natl Acad Sci USA 91: 8112-8116, 1994.
273. Sun G, Stacey MA, Schmidt M, Mori L, and Mattoli S. Interaction of mite allergens der p3 and der p9 with protease-activated receptor-2 expressed by lung epithelial cells. J Immunol 167: 1014-1021, 2001.
274. Suo Z, Wu M, Citron BA, Gao C, and Festoff BW. Persistent protease-activated receptor 4 signaling mediates thrombin-induced microglial activation. J Biol Chem. In press.
275. Suzuki Y, Nomura J, Hori J, Koyama J, Takahashi M, and Horii I. Detection and characterization of endogeneous protease associated with desquamation of stratum corneum. Arch Dermatol Res 285: 372-377, 1993.
276. Takeuchi T, Harris JL, Huang W, Yan KW, Coughlin SR, and Craik CS. Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem 275: 26333-26342, 2000.
277. Tay-Uyboco J, Poon MC, Ahmad S, and Hollenberg MD. Contractile actions of thrombin receptor-derived polypeptides in human umbilical and placental vasculature: evidence for distinct receptor systems. Br J Pharmacol 115: 569-578, 1995.
278. Tiruppathi C, Yan W, Sandoval R, Naqvi T, Pronin AN, Benovic JL, and Malik AB. G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells. Proc Natl Acad Sci USA 97: 7440-7445, 2000.
279. Toyoda N, Gabazza EC, Inoue H, Araki K, Nakashima S, Oka S, Taguchi Y, Nakamura M, Suzuki Y, Taguchi O, Imoto I, Suzuki K, and Adachi Y. Expression and cytoprotective effect of protease-activated receptor-1 in gastric epithelial cells. Scand J Gastroenterol 38: 253-259, 2003.
280. Tran T and Stewart AG. Protease-activated receptor (PAR)-independent growth and pro-inflammatory actions of thrombin on human cultured airway smooth muscle. Br J Pharmacol 138: 865-875, 2003.
281. Trejo J, Altschuler Y, Fu HW, Mostov KE, and Coughlin SR. Protease-activated receptor-1 down-regulation: a mutant HeLa cell line suggests novel requirements for PAR1 phosphorylation and recruitment to clathrin-coated pits. J Biol Chem 275: 31255-31265, 2000.
282. Trejo J and Coughlin SR. The cytoplasmic tails of protease-activated receptor-1 and substance P receptor specify sorting to lysosomes versus recycling. J Biol Chem 274: 2216-2224, 1999.
283. Trejo J, Hammes SR, and Coughlin SR. Termination of signaling by protease-activated receptor-1 is linked to lysosomal sorting. Proc Natl Acad Sci USA 95: 13698-13702, 1998.
284. Tremaine WJ, Brzezinski A, Katz JA, Wolf DC, Fleming TJ, Mordenti J, Strenkoski-Nix LC, and Kurth MC. Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study. Aliment Pharmacol Ther 16: 407-413, 2002.
285. Tsopanoglou NE and Maragoudakis ME. On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors. J Biol Chem 274: 23969-23976, 1999.
286. Turgeon VL, Lloyd ED, Wang S, Festoff BW, and Houenou LJ. Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation. J Neurosci 18: 6882-6891, 1998.
287. i oscillations in rat glioma cells. Pflügers Arch 433: 312-320, 1997.
288. Ubl JJ and Reiser G. Characteristics of thrombin-induced calcium signals in rat astrocytes. Glia 21: 361-369, 1997.
289. 2+ signalling evoked by the tethered ligand. J Physiol 525: 319-330, 2000.
290. i-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells. Neuroscience 86: 597-609, 1998.
291. Uehara A, Muramoto K, Takada H, and Sugawara S. Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2. J Immunol 170: 5690-5696, 2003.
292. Uehara A, Sugawara S, Muramoto K, and Takada H. Activation of human oral epithelial cells by neutrophil proteinase 3 through protease-activated receptor-2. J Immunol 169: 4594-4603, 2002.
293. Vaughan PJ, Pike CJ, Cotman CW, and Cunningham DD. Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J Neurosci 15: 5389-5401, 1995.
294. Vergnolle N. Proteinase-activated receptor-2-activating peptides induce leukocyte rolling, adhesion, and extravasation in vivo. J Immunol 163: 5064-5069, 1999.
295. Vergnolle N. Review article: proteinase-activated receptors: novel signals for gastrointestinal pathophysiology. Aliment Pharmacol Ther 14: 257-266, 2000.
296. Vergnolle N, Bunnett NW, Sharkey KA, Brussee V, Compton SJ, Grady EF, Cirino G, Gerard N, Basbaum AI, Andrade-Gordon P, Hollenberg MD, and Wallace JL. Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat Med 7: 821-826, 2001.
297. Vergnolle N, Derian CK, D'Andrea MR, Steinhoff M, and Andrade-Gordon P. Characterization of thrombin-induced leukocyte rolling and adherence: a potential proinflammatory role for proteinase-activated receptor-4. J Immunol 169: 1467-1473, 2002.
298. Vergnolle N, Hollenberg MD, Sharkey KA, and Wallace JL. Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw. Br J Pharmacol 127: 1083-1090, 1999.
299. Vergnolle N, Hollenberg MD, and Wallace JL. Pro- and anti-inflammatory actions of thrombin: a distinct role for proteinase-activated receptor-1 (PAR1). Br J Pharmacol 126: 1262-1268, 1999.
300. Vergnolle N, MacNaughton WK, Al-Ani B, Saifeddine M, Wallace JL, and Hollenberg MD. Proteinase-activated receptor 2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transport. Proc Natl Acad Sci USA 95: 7766-7771, 1998.
301. Vogel SM, Gao X, Mehta D, Ye RD, John TA, Andrade-Gordon P, Tiruppathi C, and Malik AB. Abrogation of thrombin-induced increase in pulmonary microvascular permeability in PAR-1 knockout mice. Physiol Genomics 4: 137-145, 2000.
302. Vouret-Craviari V, Auberger P, Pouyssegur J, and Van Obberghen-Schilling E. Distinct mechanisms regulate 5-HT2 and thrombin receptor desensitization. J Biol Chem 270: 4813-4821, 1995.
303. Vouret-Craviari V, Boquet P, Pouyssegur J, and Van Obberghen-Schilling E. Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of Rho proteins in endothelial barrier function. Mol Biol Cell 9: 2639-2653, 1998.
304. Vouret-Craviari V, Grall D, Chambard JC, Rasmussen UB, Pouyssegur J, and Van Obberghen-Schilling E. Post-translational and activation-dependent modifications of the G protein-coupled thrombin receptor. J Biol Chem 270: 8367-8372, 1995.
305. Vu TK, Hung DT, Wheaton VI, and Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64: 1057-1068, 1991.
306. Vu TK, Wheaton VI, Hung DT, Charo I, and Coughlin SR. Domains specifying thrombin-receptor interaction. Nature 353: 674-677, 1991.
307. Wakita H, Furukawa F, and MT. Thrombin and trypsin stimulate granulocyte-macrophage colony-stimulating factor and interleukin-6 gene expression in cultured normal human keratinocytes. Proc Assoc Am Phys 109: 190-207, 1997.
308. Wang H and Reiser G. Thrombin signaling in the brain: the role of protease-activated receptors. J Biol Chem 384: 193-202, 2003.
309. Wang H, Ubl JJ, and Reiser G. Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling. Glia 37: 53-63, 2002.
310. Wang H, Ubl JJ, Stricker R, and Reiser G. Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways. Am J Physiol Cell Physiol 283: C1351-C1364, 2002.
311. Wang Y, Zhou Y, Szabo K, Haft CR, and Trejo J. Down-regulation of protease-activated receptor-1 is regulated by sorting nexin 1. Mol Biol Cell 13: 1965-1976, 2002.
312. Weinstein JR, Gold SJ, Cunningham DD, and Gall CM. Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J Neurosci 15: 2906-2919, 1995.
313. Weiss EJ, Hamilton JR, Lease KE, and Coughlin SR. Protection against thrombosis in mice lacking PAR3. Blood 100: 3240-3244, 2002.
314. Widmann C, Gibson S, Jarpe MB, and Johnson GL. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79: 143-180, 1999.
315. 2+ and mitogen-activated protein kinase regulation. J Biol Chem 269: 1889-1895, 1994.
316. Wojtukiewicz MZ, Tang DG, Ben-Josef E, Renaud C, Walz DA, and Honn KV. Solid tumor cells express functional "tethered ligand" thrombin receptor. Cancer Res 55: 698-704, 1995.
317. Xu WF, Andersen H, Whitmore TE, Presnell SR, Yee DP, Ching A, Gilbert T, Davie EW, and Foster DC. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 95: 6642-6646, 1998.
318. Yang PC, Berin MC, Yu L, and Perdue MH. Mucosal pathophysiology and inflammatory changes in the late phase of the intestinal allergic reaction in the rat. Am J Pathol 158: 681-690, 2001.
319. Yu Z, Ahmad S, Schwartz JL, Banville D, and Shen SH. Protein-tyrosine phosphatase SHP2 is positively linked to proteinase-activated receptor 2-mediated mitogenic pathway. J Biol Chem 272: 7519-7524, 1997.